id: alternative_aws_treatment_availability_to_treatment_conversion_to_intensive_care
name: Alternative Treatment Options for Alcohol Withdrawal â†’ Conversion to Higher
  Level of Care
from_node:
  node_id: alternative_aws_treatment_availability
  node_name: Alternative Treatment Options for Alcohol Withdrawal
to_node:
  node_id: treatment_conversion_to_intensive_care
  node_name: Conversion to Higher Level of Care
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Gabapentin and baclofen combination provides effective symptom management
  for mild AWS without respiratory depression risk of benzodiazepines'
- 'Step 2: Effective alternative treatment reduces need for escalation to benzodiazepines
  and associated intensive monitoring requirements'
- 'Step 3: Lower escalation rates reduce transfers to higher levels of care (ICU or
  specialized units), maintaining patients in general acute care settings'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Kristina Karapetyan et al. 2023. "Evaluation of Gabapentin and
    Baclofen Combination for Inpatient Management of Alcohol Withdrawal Syndrome.."
    *Federal practitioner : for the health care professionals of the VA, DoD, and
    PHS*. https://doi.org/10.12788/fp.0362'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:06.747060'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
moderators:
- name: withdrawal_severity_at_presentation
  direction: weakens
  strength: strong
  description: Patients presenting with moderate to severe AWS may still require benzodiazepine
    therapy and intensive monitoring regardless of initial treatment choice
- name: institutional_formulary_policies
  direction: strengthens
  strength: moderate
  description: Healthcare systems with established protocols for gabapentin/baclofen
    use may see greater reductions in care escalation through early intervention
